Today’s New York TImes Magazine has a big article about Dr. Alexander Shulgin, who invented more than 100 hallucinogens and was, in all likelihood, the first person to try Ecstasy (MDMA) in humans. Shulgin is a really good guy, he’s previously been a consultant for the DEA, and he’s got a wicked-cool lab in California that I’ve visited on multiple occasions. Even if you’re not interested by psychedelic drugs, you should read this article — because Ecstasy is increasingly being put into trials as a possible cure for PTSD and other psychological disorders.
Investing in people is key to successful transformation
People-related factors like talent attraction and retention and clear top-down communication will determine whether your transformation progresses or stalls.
The way forward: Merging IT and operations
Digital transformation in any industry begins with bridging the gap between two traditionally separate teams.
Work reinvented: Tech will drive the office evolution
As organizations navigate a new world of hybrid work, tech innovation will be crucial for employee connection and collaboration.
Be a good example
"It was in the newspaper, but the towers fell the next day, and what I’d done was quickly lost."
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.